Press Release (ePRNews.com) - Coral Springs, Florida - Oct 26, 2016 - ALS is an incurable disease, and the last year has seen some monumental medical and scientific strides to finding a cure. In the interim, many patients with amyotrophic lateral sclerosis (PALS) are faced with deteriorating health, progressive symptoms and a decline in quality of life. For many patients, following the Deanna Protocol® of nutritional support has afforded them an improvement in their quality of life.
As a relatively new company, Simplesa’s® commitment to patients with ALS (PALS) has been globally recognized. In 2014, Simplesa® signed a licensing agreement with the 501(c)3 nonprofit WINNING THE FIGHT, INC. to provide products specifically formulated for people that are following the Deanna Protocol®. The Deanna Protocol® is a nutritional supplementation program based on Dr. Vincent Tedone’s research on ALS or Lou Gehrig’s Disease. This protocol uses dietary supplements to support specific nutritional needs of patients with ALS.
ALS patients were having success following the Deanna Protocol®, but it was too complex and expensive the way it was distributed. Simplesa® formulated products specifically for these ALS patients to simplify their regimen and lower the cost of the products they take.
Steve Margolis, Simplesa
Over the past few years, with PALS’ increasing success using the Deanna Protocol, Simplesa® created has various options in which the individual supplements are combined for increased convenience. The regimen’s popularity and success has enabled Simplesa® to lower the costs of the Deanna Protocol® packages and pass those savings on to consumers. The company is now offering a broader spectrum of bundle choices at lower prices for ALS patients, ranging from “Core” and “Plus” to “Comprehensive.”
The growing number of followers of the Deanna Protocol is based on two very important factors: many PALS are seeing increased quality of life using the nutritional therapy, and comprehensive personalized customer support.
Simplesa® is consistently ranked in the top ten percent for customer service, in Customer Satisfaction reviews, ALS forums, and by PALS.
Simplesa® now has well over 3,000 global PALS as customers, who are regularly ordering and reporting positive results on the Deanna Protocol for their ALS symptoms and their overall quality of life.
Every day, an average of over 15 people in the United States are newly diagnosed with ALS. As many as 30,000 Americans may currently be affected by ALS. Annually, ALS is responsible for two deaths per every 100,000 people. The average life expectancy of a person with ALS is two to five years from time of diagnosis.
More than 5 percent of the current ALS population is regularly using the Deanna Protocol by Simplesa® and usage is growing every day.
Real experiences and feedback are reported to Simplesa® each day on how the Deanna Protocol is helping PALS. One recent experience is reported by Jeannie and Billy Scotland:
My partner started the Deanna Protocol a month ago. I bought the products separately and from lots of different sites. Also, I had to study every tablet and how many times a day and how many mg to give him. Took a long time but after only a month his walking has improved his speech improved his spasms improved and his energy levels have improved a lot. After spending almost 300 quid on all the supplements I contacted Simplesa® via email and Mike called me and we worked out a simple manageable affordable way of getting everything we need for this month’s and the coming months. They really care and trust me every penny is worth the knowledge we r doing something to slow down this horrible horrendous disease until they have a cure. riluzile offers 3 months this offers years of independence you wouldn’t have had before. I swear it’s only been a month and we are seeing benefits I will keep you all posted on my partner’s progress. Thank you Simplesa® for supporting Dr. Tedone’s fight to save our loved ones. Let’s hope everyone with ALS hears about all your good work and the studies that have been going on for years that our medical professionals should be telling us about.
This PALS’ experience is just one of hundreds reported on Simplesa’s web site. This does not include the hundreds of other positive experiences reported on other retailers’ sites selling the Deanna Protocol® by Simplesa®. The Ice Bucket Challenge a couple years ago brought heightened attention online and across social media to the needs of PALS and the urgency of a cure for ALS. The additional attention also raised visibility of the Deanna Protocol® by Simplesa® as a supportive protocol for PALS. Simplesa® is providing real time support and apersonalized approach to ALS supportive nutrition every day for PALS.
This increase in quality of life has not gone unnoticed by physicians who are now starting to recommend the Deanna Protocol® to their ALS patients. Hundreds of practitioners across the world are actively partnered with Simplesa®, and the Simplesa® brand continues to gain traction as brand awareness, reputation and effectiveness becomes more widely known. If you have questions about how Simplesa® can help you or a loved one, contact them today at (888)-578-5528.
About Simplesa® Simplesa® was founded in 2013 because it saw a need and had a solution. ALS patients were having success following the Deanna Protocol®, but it was too complex and expensive the way it was distributed. Simplesa® formulated products specifically for these ALS patients to simplify their regimen and lower the cost of the products they take. The brand is continuously on the lookout for other similar situations to help patients keep their supplemental and nutritional regimes simple.
Corporate Contact Steve Margolis Steve (at) simplesanutrition.com
DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.